GLG News in Healthcare

Beta trial implies that Avastin adds to the effectiveness of the other Genentech drug, Tarceva There is an attempt to change treatment gudelines in second line non small treatment

Yes the trend will continue, but with limitations, for now. China IS most definitely already a source for pharmaceutical manufacturing, but has a long way to go before becoming an independent creator of pharmaceutical intellectual property. Once it can, then outsourcing will really take off.

Gamma secretase inhibitors are one of several kinds of drugs being studied for the prevention/amelioration of Alzheimer's.  In concept they make sense.

As the biggest pharmaceutical company, Pfizer's R & D needs to be more productive than any other company's if it is to survive and prosper. But Pfizer must have new products that are big if they are to make an impact on its bottom line. The conundrum is that disease is a diffuse market, with few very big pharmaceutical products to treat it, and far more smaller ones. Thus in...

The primary goal was improved survival- NOT REACHED!!

Yes, there are elevated radon levels in some homes, and, yes, there are patients with lung cancer in some homes, as well. But the connection, while it might be intuitive, remains to be solidified.

This eyeglass lens designer, Ron Blum has created a new type of Progressive Addition Lens about 6 years ago. It created a new market in Ultra-Premium lenses. Now he is attempting to create a new lens for computer users. I look forward to its introduction next month, and to the creation of new profit opportunity from selling his new design.

Rising costs in China makes it less attractive Increased regulatory oversight will increase cost and in the long run improve quality Will all of the problems in China result in better products for both the global market and China  or just for the exports?

Of course anticholinergic drugs leave sympathetic stimulation unbalanced. They, therefore, may act in certain individuals as weak sympathomimetic producing arrhythmias, hypertension, tachycardia, vasoconstriction etc. with know sequences, such as atherosclerosis, cerebrovascular and coronary effects. They should be avoided in individuals with well established risk factors.

How somebody can possibly come up with mentioned estimation: "...20,000 people die from radon-induced lung cancer every year..."? Where is the denominator: how many non-smokers with documented constant radon exposure acquire lung malignancy?